Dyadic International Inc

General ticker "DYAI" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $50.1M

Dyadic International Inc does not follow the US Stock Market performance with the rate: -14.9%.

Estimated limits based on current volatility of 10.0%: low 1.68$, high 2.06$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.11$, 2.47$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.38$, 2.90$]

Financial Metrics affecting the DYAI estimates:

  • Negative: Non-GAAP EPS, $ of -0.24 <= 0.10
  • Negative: Operating profit margin, % of -73.95 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -12.51 <= 2.35
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share, $ of 0 <= 0
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Investing cash flow per share, $ of 0.26 > -0.12

Similar symbols

Short-term DYAI quotes

Long-term DYAI plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $2.40MM $2.93MM $2.90MM
Operating Expenses $17.13MM $13.05MM $11.13MM
Operating Income $-14.73MM $-10.12MM $-8.23MM
Non-Operating Income $1.66MM $0.38MM $1.43MM
R&D Expense $8.39MM $4.50MM $3.30MM
Income(Loss) $-13.07MM $-9.74MM $-6.80MM
Taxes $-0.15MM $-0.36MM $0.00MM
Profit(Loss) $-12.92MM $-9.37MM $-6.80MM
Stockholders Equity $18.39MM $11.09MM $5.88MM
Assets $21.30MM $13.71MM $8.22MM
Operating Cash Flow $-11.28MM $-8.08MM $-6.73MM
Investing Cash Flow $5.22MM $-2.37MM $7.45MM
Financing Cash Flow $1.23MM $0.54MM $0.00MM
Earnings Per Share* $-0.46 $-0.33 $-0.24

* EPS are Split Adjusted, recent splits may be reflected with a delay.